Enhanced proliferation of neural stem cells in a collagen hydrogel incorporating engineered epidermal growth factor

Biomaterials

Volumn 32, Issue 21, 2011, Pages 4737-4743

  Egawa, Edgar Y ^a   Kato, Koichi ^a   Hiraoka, Makiko ^a   Nakaji Hirabayashi, Tadashi ^a   Iwata, Hiroo ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Collagen; ECM (extracellular matrix); Growth factors; Hydrogel; Neural cell; Stem cell

Indexed keywords

CELL POPULATIONS; COLLAGEN BINDING DOMAIN; COMPOSITE HYDROGELS; ECM (EXTRACELLULAR MATRIX); EMBEDDED CELLS; ENGRAFTMENT; EPIDERMAL GROWTH FACTORS; GENE EXPRESSION ANALYSIS; GROWTH FACTORS; LIVING CELL; MICROENVIRONMENTS; MITOGENS; NEURAL CELLS; NEURAL STEM CELL; OLIGODENDROCYTES; PARKINSON'S DISEASE; RAT BRAIN; RECOMBINANT DNA TECHNOLOGY; TRANSPLANTED CELLS;

CELL CULTURE; CELL PROLIFERATION; COLLAGEN; DISEASE CONTROL; ENZYME INHIBITION; GENE EXPRESSION; GENETIC ENGINEERING; PEPTIDES; STEM CELLS; TISSUE;

HYDROGELS;

COLLAGEN; COLLAGEN BINDING PROTEIN; EPIDERMAL GROWTH FACTOR; POLYPEPTIDE;

ANIMAL CELL; ARTICLE; ASTROCYTE; BIOENGINEERING; CELL POPULATION; CELL PROLIFERATION; CELL SUBPOPULATION; CELL SURVIVAL; CONTROLLED STUDY; EMBRYO; FETUS; GENE EXPRESSION; HYDROGEL; MICROENVIRONMENT; NEURAL STEM CELL; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; OLIGODENDROGLIA; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; RAT; RECOMBINANT DNA TECHNOLOGY;

ANIMALS; BIOCOMPATIBLE MATERIALS; BIOLOGICAL MARKERS; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN; EPIDERMAL GROWTH FACTOR; GENE EXPRESSION; HYDROGELS; MATERIALS TESTING; NEURAL STEM CELLS; RATS; RATS, SPRAGUE-DAWLEY; RATS, TRANSGENIC; RECOMBINANT FUSION PROTEINS;

RATTUS;

EID: 79955750313     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.03.033     Document Type: Article

References (32)

1. Temple S. The development of neural stem cells. Nature 2001, 414:112-117.
2. Pevny L., Rao M.S. The stem cell menagerie. Trends Neurosci 2003, 26:351-359.
3. Kim S.U. Human neural stem cells genetically modified for brain repair in neurological disorders. Neuropathology 2004, 24(3):159-171.
4. Piccini P., Pavese N., Hagell P., Reimer J., Björklund A., Oertel W.H., et al. Factors affecting the clinical outcome after neural transplantation in Parkinson's disease. Brain 2005, 128:2977-2986.
5. Liu J., Huang H.Y. How to improve the survival of the fetal ventral mesencephalic cell transplanted in Parkinson's disease?. Neurosci Bull 2007, 23:377-382.
6. Nakao N., Frodl E.M., Duan W.M., Widner H., Brundin P. Lazaroids improve the survival of grafted rat embryonic dopamine neurons. Proc Natl Acad Sci USA 1994, 91:12408-12412.
7. Rosenblad C., Martinez-Serrano A., Björklund A. Glial cell line-derived neurotrophic factor increases survival, growth and function of intrastriatal fetal nigral dopaminergic grafts. Neurosci 1996, 75:979-985.
8. Schierle G.S., Hansson O., Leist M., Nicotera P., Winder H., Brundin P. Caspase inhibition reduces apoptosis and increases survival of nigral transplants. Nat Med 1999, 5:97-100.
9. Studer L., Tabar V., McKay R.D. Transplantation of expanded mesencephalic precursors leads to recoveryin parkinsonian rats. Nat Neurosci 1998, 1:290-295.
10. Carvey P.M., Ling Z.D., Sortwell C.E., Pitzer M.R., McGuire S.O., Storch A., et al. A clonal line of mesencephalic progenitor cells converted to dopamine neurons by hematopoietic cytokines: a source of cells for transplantation in Parkinson's disease. Exp Neurol 2001, 171:98-108.
11. Bible E., Chau D.Y.S., Alexander M.R., Price J., Shakesheff K.M., Modo M. The support of neural stem cells transplanted into stroke-induced brain cavities by PLGA particles. Biomaterials 2009, 30:2985-2994.
12. O'Keeffe F.E., Scott S.A., Tyers P., O'Keeffe G.W., Dalley J.W., Zufferey R., et al. Induction of A9 dopaminergic neurons from neural stem cells improves motor function in an animal model of Parkinson's disease. Brain 2008, 131:630-641.
13. Lee H.J., Lim I.J., Lee M.C., Kim S.U. Human neural stem cells genetically modified to overexpress brain-derived neurotrophic factor promote functional recovery and neuroprotection in a mouse stroke model. J Neurosci Res 2010, 88:3282-3294.
14. Marchionini D.M., Collier T.J., Camargo M., McGuire S., Pitzer M., Sortwell C.E. Interference with Anoikis-induced cell death of dopamine neurons: implications for augmenting embryonic graft survival in a rat model of Parkinson's disease. J Comp Neurol 2003, 464:172-179.
15. Tambur A.R. Transplantation immunology and the central nervous system. Neurol Res 2004, 26:243-255.
16. Hiraoka M., Kato K., Nakaji-Hirabayashi T., Iwata H. Enhanced survival of neural cells embedded in hydrogels composed of collagen and laminin-derived cell adhesive peptide. Bioconjugate Chem 2009, 20:976-983.
17. Brännvall K., Bergman K., Wallenquist U., Svahn S., Bowden T., Hilborn J., et al. Enhanced neuronal differentiation in a three dimensional collagen hyaluronan matrix. J Neurosci Res 2007, 85:2138-2146.
18. Watanabe K., Nakamura M., Okano H., Toyama Y. Establishment of three-dimensional culture of neural stem/progenitor cells in collagen type 1 gel. Restor Neurol Neurosci 2007, 25:109-117.
19. Itoh T., Satou T., Dote K., Hashimoto S., Ito H. Effect of basic fibroblast growth factor on cultured rat neural stem cell in three dimensional collagen gel. Neurol Res 2005, 27:429-432.
20. Mahoney M.J., Anseth K.S. Contrasting effects of collagen and bFGF-2 on neural cell function in degradable synthetic PEG hydrogels. J Biomed Mater Res A 2007, 81:269-278.
21. Nakajima M., Ishimuro T., Kato K., Ko I.-K., Hirata I., Arima Y., et al. Combinatorial protein display for the cell-based screening of biomaterials that direct neural stem cell differentiation. Biomaterials 2007, 28:1048-1060.
22. Uemura M., Refaat M.M., Shinoyama M., Hayashi H., Hashimoto N., Takahashi1 J. Matrigel supports survival and neuronal differentiation of grafted embryonic stem cell-derived neural precursor cells. J Neurosci Res 2010, 88:542-551.
23. Reynolds B.A., Tetzlaff W., Weiss S.A. A multipotent EGF-responsive striatal embryonic progenitor cell produces neurons and astrocytes. J Neurosci 1992, 12:4565-4574.
24. Gonzalez-Perez O., Quiñones-Hinojosa A. Dose-dependent effect of EGF on migration and differentiation of adult subventricular zone astrocytes. Glia 2010, 58:975-983.
25. Sun D., Bullock M.R., Altememi N., Zhou Z., Hagood S., Rolfe A., et al. The effect of epidermal growth factor in the injured brain after trauma in rats. J Neurotrauma 2010, 27:923-938.
26. Huizinga E.G., Martijn van der Plas R., Kroon J., Sixma J.J., Gros P. Crystal structure of the A3 domain of human von Willebrand factor implications for collagen binding. Structure 1997, 5:1147-1156.
27. Auton M., Cruz M.A., Moake J. Conformational stability and domain unfolding of the von Willebrand factor A domains. J Mol Biol 2007, 366:986-1000.
28. Nakaji-Hirabayashi T., Kato K., Arima Y., Iwata H. Oriented immobilization of epidermal growth factor onto culture substrates for the selective expansion of neural stem cells. Biomaterials 2007, 28:3517-3529.
29. Kato K., Sato H., Iwata H. Ultrastructural study on the specific binding of genetically engineered epidermal growth factor to type I collagen fibrils. Bioconjugate Chem 2007, 18:2137-2143.
30. Kato K., Sato H., Iwata H. Immobilization of histidine-tagged recombinant proteins onto micropatterned surfaces for cell-based functional assays. Langmuir 2005, 21:7071-7075.
31. Nakaji-Hirabayashi T., Kato K., Iwata H. Surface-anchoring of spontaneously dimerized epidermal growth factor for highly selective expansion of neural stem cells. Bioconjugate Chem 2009, 20:102-110.
32. Prestrelski S.J., Arakawa T., Wu C.-S.C., O'Neal K.D., Westcott K.R., Narhi L.O. Solution structure and dynamics of epidermal growth factor and transforming growth factor α. J Biol Chem 1992, 267:319-322.